68 related articles for article (PubMed ID: 21203460)
1. Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
Fowler CJ; Hammarsten P; Bergh A
PLoS One; 2010 Dec; 5(12):e15205. PubMed ID: 21203460
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
3. Towards the use of non-psychoactive cannabinoids for prostate cancer.
Pacher P
Br J Pharmacol; 2013 Jan; 168(1):76-8. PubMed ID: 22849856
[TBL] [Abstract][Full Text] [Related]
4. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid Receptor-1 suppresses M2 macrophage polarization in colorectal cancer by downregulating EGFR.
Deng YM; Zhao C; Wu L; Qu Z; Wang XY
Cell Death Discov; 2022 May; 8(1):273. PubMed ID: 35641479
[TBL] [Abstract][Full Text] [Related]
7. Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients.
Morin-Buote J; Ennour-Idrissi K; Poirier É; Lemieux J; Furrer D; Burguin A; Durocher F; Diorio C
J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575629
[TBL] [Abstract][Full Text] [Related]
8. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of HER2-CB
Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
[TBL] [Abstract][Full Text] [Related]
11. Gα
Finlay DB; Cawston EE; Grimsey NL; Hunter MR; Korde A; Vemuri VK; Makriyannis A; Glass M
Br J Pharmacol; 2017 Aug; 174(15):2545-2562. PubMed ID: 28516479
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance.
Pyszniak M; Tabarkiewicz J; Łuszczki JJ
Onco Targets Ther; 2016; 9():4323-36. PubMed ID: 27486335
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation.
Freund P; Porpaczy EA; Le T; Gruber M; Pausz C; Staber P; Jäger U; Vanura K
PLoS One; 2016; 11(6):e0156693. PubMed ID: 27248492
[TBL] [Abstract][Full Text] [Related]
14. The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.
Cipriano M; Gouveia-Figueira S; Persson E; Nording M; Fowler CJ
BMC Res Notes; 2014 Jul; 7():441. PubMed ID: 25012825
[TBL] [Abstract][Full Text] [Related]
15. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
Häggström J; Cipriano M; Forshell LP; Persson E; Hammarsten P; Stella N; Fowler CJ
Prostate; 2014 Aug; 74(11):1107-17. PubMed ID: 24913716
[TBL] [Abstract][Full Text] [Related]
16. 18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.
Emonds KM; Koole M; Casteels C; Van den Bergh L; Bormans GM; Claus F; De Wever L; Lerut E; Van Poppel H; Joniau S; Dumez H; Haustermans K; Mortelmans L; Goffin K; Van Laere K; Deroose CM; Mottaghy FM
EJNMMI Res; 2013 Aug; 3(1):59. PubMed ID: 23915639
[TBL] [Abstract][Full Text] [Related]
17. Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
Hammarsten P; Cipriano M; Josefsson A; Stattin P; Egevad L; Granfors T; Fowler CJ
PLoS One; 2012; 7(10):e47994. PubMed ID: 23133535
[TBL] [Abstract][Full Text] [Related]
18. Monoacylglycerol lipase - a target for drug development?
Fowler CJ
Br J Pharmacol; 2012 Jul; 166(5):1568-85. PubMed ID: 22428756
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system in prostate cancer.
Díaz-Laviada I
Nat Rev Urol; 2011 Sep; 8(10):553-61. PubMed ID: 21912423
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
